WordNet

any malignant tumor derived from epithelial tissue; one of the four major types of cancer

PrepTutorEJDIC

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 高リスクの子宮体癌に対する補助化学療法 adjuvant treatment of high risk endometrial cancers
2. ER／PR陰性、HER2陰性（トリプルネガティブ）乳癌の疫学、危険因子および
臨床的アプローチ epidemiology risk factors and the clinical approach to er pr negative her2 negative triple negative breast cancer
3. 進行非小細胞肺癌に対する低分子上皮成長因子受容体阻害剤 small molecule epidermal growth factor receptor inhibitors for advanced non small cell lung cancer
4. 頭頸部の局所進行扁平上皮癌：化学療法と放射線療法を併用するアプローチ locally advanced squamous cell carcinoma of the head and neck approaches combining chemotherapy and radiation therapy
5. 結腸直腸癌長期生存患者へのアプローチ approach to the long term survivor of colorectal cancer

Davis JE1, Nemesure B, Mehmood S, Nayi V, Burke S, Brzostek SR, Singh M.
Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry.Appl Immunohistochem Mol Morphol.2016 Jan;24(1):20-5. doi: 10.1097/PAI.0000000000000223.
BACKGROUND: A subset of patients with ductal carcinoma in situ (DCIS) experience recurrence or progression to invasive cancer. Current clinical practice is not reliably guided by DCIS recurrence prediction, although recurrence risk for invasive breast cancer can now be assessed. We analyzed a panel
PMID 26317313

CT Radiogenomic Characterization of EGFR, K-RAS, and ALK Mutations in Non-Small Cell Lung Cancer.

Rizzo S1, Petrella F2, Buscarino V3, De Maria F3, Raimondi S4, Barberis M5, Fumagalli C5, Spitaleri G6, Rampinelli C7, De Marinis F6, Spaggiari L2, Bellomi M7,3.
European radiology.Eur Radiol.2016 Jan;26(1):32-42. doi: 10.1007/s00330-015-3814-0. Epub 2015 May 9.
OBJECTIVES: To assess the association between CT features and EGFR, ALK, KRAS mutations in non-small cell lung cancer.METHODS: Patients undergoing chest CT and testing for the above gene mutations were included. Qualitative evaluation of CTs included: lobe; lesion diameter; shape; margins; ground-gl
PMID 25956936

Predictive value of pAKT/PTEN expression in oral squamous cell carcinoma treated with cetuximab-based chemotherapy.

Lyu J1, Song H2, Tian Z3, Miao Y4, Ren G2, Guo W5.
Oral surgery, oral medicine, oral pathology and oral radiology.Oral Surg Oral Med Oral Pathol Oral Radiol.2016 Jan;121(1):67-72. doi: 10.1016/j.oooo.2015.09.002. Epub 2015 Sep 7.
OBJECTIVE: Molecular alterations in downstream effectors of epidermal growth factor receptor may confer resistance to epidermal growth factor receptor inhibitors. Our aim is to investigate whether PTEN/pAKT expression predicts response to cetuximab-based chemotherapy in oral squamous cell carcinoma.
PMID 26577500